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Abstract
Objective To assess the failure rate of cemented, uncemented, hybrid,
and reverse hybrid total hip replacements in patients aged 55 years or
older.
Design Register study.
Setting Nordic Arthroplasty Register Association database (combined
data from Sweden, Norway, Denmark, and Finland).
Participants 347 899 total hip replacements performed during
1995-2011.
Main outcome measures Probability of implant survival (Kaplan-Meier
analysis) along with implant survival with revision for any reason as
endpoint (Cox multiple regression) adjusted for age, sex, and diagnosis
in age groups 55-64, 65-74, and 75 years or older.
Results The proportion of total hip replacements using uncemented
implants increased rapidly towards the end of the study period. The 10
year survival of cemented implants in patients aged 65 to 74 and 75 or
older (93.8%, 95% confidence interval 93.6% to 94.0% and 95.9%,
95.8% to 96.1%, respectively) was higher than that of uncemented
(92.9%, 92.3% to 93.4% and 93.0%, 91.8% to 94.0%), hybrid (91.6%,
90.9% to 92.2% and 93.9%, 93.1% to 94.5%), and reverse hybrid (90.7%,
87.3% to 93.2% and 93.2%, 90.7% to 95.1%) implants. The survival of
cemented (92.2%, 91.8% to 92.5%) and uncemented (91.8%, 91.3% to
92.2%) implants in patients aged 55 to 64 was similar. During the first
six months the risk of revision with cemented implants was lower than
with all other types of fixation in all age groups.
Conclusion The survival of cemented implants for total hip replacement
was higher than that of uncemented implants in patients aged 65 years
or older. The increased use of uncemented implants in this age group
is not supported by these data. However, because our dataset includes
only basic information common to all national registers there is potential
for residual confounding.
Introduction
Observational studies are efficient in assessing data on the
survival of implants used for total hip replacements. The role
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of single, randomised controlled studies should not be
over-emphasised in clinical decision making.1 2 Arthroplasty
registers in Nordic countries have existed for a long time.3-6 The
Nordic Arthroplasty Register Association was established in
2007 by Sweden, Norway, and Denmark to improve the quality
of hip and knee arthroplasty through collaboration of research.7
After Finland joined the association in 2010 the total population
of the countries involved was 25.5 million. By conducting
multinational register studies, comprehensive patient populations
can be studied in high numbers thereby improving statistical
precision. The number of hip replacements recorded in the
Nordic Arthroplasty Register Association database (536 962)
covering 1995 to 2011 is comparable to that of the National
Joint Registry of England and Wales (458 568, covering 2003
to 2011)8 and the Australian Register (223 339, covering
September 1999 to 2011).9 However, the follow-up time in the
Nordic arthroplasty database is longer, which can be expected
to have an influence on the outcome in terms of increased
incidence of long term complications, such as loosening of
implants.
Register based studies as well as systematic reviews have
documented a better overall survival rate of cemented compared
with uncemented implants for total hip replacements based on
data from national arthroplasty registers.7-15 However, Nordic
orthopaedic surgeons have followed the trend of an increased
use of uncemented implants, similar to colleagues in western
European countries,8 Australia,9 and the United States.15 16
Based on information from the Nordic Arthroplasty Register
Association database, we assessed the survival of cemented,
uncemented, hybrid (uncemented cup with cemented stem), and
reverse hybrid (cemented cup with uncemented stem) implants
for total hip replacements in patients aged 55 years or older.
Methods
Sources of data
The hip arthroplasty registers of Sweden and Denmark and the
arthroplasty registries of Norway and Finland participated in
the present study. From 1995 all four registers have used
individual based registration of operations and patients.
Therefore the data include total hip replacements performed
during 1995-2011. Aminimal dataset was created by the Nordic
Arthroplasty Register Association to contain data that all four
registers could deliver.7 The database includes information on
the vital status of patients, enabling the survival of implants to
be analysed.
Within each national register we performed selection and
transformation of the datasets to equal the minimal dataset and
deidentified the patients, which included deletion of their
national civil registration numbers. We then merged the
anonymised data into a common database. We treated the data
with full confidentially, according to the rules of the respective
countries. This included access to the common database, which
was limited to the authors of the present paper. It is not possible
to identify patients at an individual level, either in this paper or
in the database. The quality of data in the Nordic registries is
high.17-21
Inclusion and exclusion criteria
We included patients aged 55 years or older with a stemmed
implant for total hip replacement (the results of younger patients
will be analysed in a separate study). Overall, the Nordic
Arthroplasty Register Association database contained data on
536 962 hip replacements. If a patient had both hips replaced,
we included data for only the first owing to potential bias of
bilaterality.22 23We also wanted to ensure that the analyses were
not biased by potential errors in recording laterality. In total we
excluded 3227 hip resurfacings, 88 723 hip replacements owing
to bilaterality, 38 procedures that were not primary operations,
and 49 424 owing to young age (<55 years). We also excluded
three patients aged more than 100 years because of suspected
coding errors and 1694 hip replacements because the type of
fixation was not mentioned. We excluded 20 hip replacements
because of ambiguity over the laterality of the first operation,
45 208 because the procedure was undertaken for hip fracture,
and 726 owing to a missing diagnosis. Altogether we included
347 899 total hip replacements: 232 603 using cemented
implants, 71 454 uncemented, 28 215 hybrid (uncemented cup
with cemented stem), and 15 627 reverse hybrid (cemented cup
with uncemented stem).
Statistical analysis
We assessed the descriptive statistics of participants. We used
Kaplan-Meier survival analysis to assess the probability of
implant survival at 10 and 15 years. We determined survival
data only when at least 100 total hip replacements were at risk.
Patients were followed from the date of primary total hip
replacement and censored at death or outcome, whichever came
first. Outcome was defined as removal or exchange of at least
one of the components, including liner exchanges of uncemented
cups, for any reason. We used a Cox multiple regression model
for different age groups to assess implant survival and hazard
ratio of any revision as endpoint, with 95% confidence intervals
and adjustment for age and diagnosis. Because none of the
variables used for adjustment fulfilled the proportional hazard
assumption for the whole study period, we stratified the model
by sex and diagnosis. As type of fixation did not fulfill the
proportional hazards assumption, we also split the follow-up
period into one year intervals, except the first year, which we
divided into two periods. We presented implant survival data
for three age groups: 55-64, 65-74, and 75 years or older. These
age groups were chosen to allow comparison of our results and
data derived from other national registers using the same age
groups.8 9 The Wald test was used to calculate the P values for
data obtained from the Cox multiple regression analyses. We
considered differences between groups to be statistically
significant if the P values were less than 0.05 in a two tailed
test.
To assess the time period effect we performed Kaplan-Meier
analyses separately for total hip replacements during 1995-99,
2000-05, and 2006-11.
Results
The mean follow-up time for total hip replacements was 7.0
(range 0-17) years for cemented total hip replacements, 4.9
(0-17) for uncemented, 7.5 (0-17) for hybrid, and 3.4 (0-16.9)
for reverse hybrid. The proportion of men was 39.4% (table
1⇓). The proportion of total hip replacements using uncemented
implants increased rapidly towards the end of the study period
(fig 1⇓). Of all total hip replacements, the proportion in 1995
and 2011 using, respectively, uncemented implants was 9.6%
(1641/17 080) and 39.4% (9328/23 693), hybrid implants was
9.2% (1563/17 080) and 4.7% (1119/23 693), and reverse hybrid
implants was 0.2% (40/17 080) and 12.3% (2921/23 693).
Table 2⇓ and figure 2⇓ show unadjusted Kaplan-Meier survival
curves with 95% confidence intervals for implants at 10 and 15
years by fixation type and age group.
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Table 3⇓ presents the reasons for revision during the first six
months postoperatively. Periprosthetic fractures were a more
common reason for revision among uncemented total hip
replacements (27% (333/1213) of all revisions) than among
cemented total hip replacements (4% (57/1535) of all revisions).
Supplementary appendix table 1 and figure 3⇓ present by age
group the adjusted hazard ratios, 95% confidence intervals, and
P values for uncemented, hybrid, and reverse hybrid total hip
replacements, with cemented total hip replacement as the
reference group.
10 year implant survival by age group
55-64 years—The 10 year survival of cemented implants (92.2%,
95% confidence interval 91.8% to 92.5%) was similar to that
of uncemented and reverse hybrid implants (91.8%, 91.3% to
92.2% and 92.4%, 90.9% to 93.7%, respectively). The 10 year
survival of hybrid implants (90.0%, 89.2% to 90.7%) was
inferior to that of cemented implants (table 2 and fig 2).
65-74 years—The 10 year survival of cemented implants (93.8%,
93.6% to 94.0%) was higher than that of uncemented, hybrid,
and reverse hybrid implants (92.9%, 92.3% to 93.4%, 91.6,
90.9% to 92.2%, and 90.7%, 87.3% to 93.2%, respectively)
(table 2 and fig 2).
≥75 years—The 10 year survival of cemented implants (95.9%,
95.8% to 96.1%) was higher than that of uncemented and hybrid
implants (93.0%, 91.8% to 94.0% and 93.9%, 93.1% to 94.5%,
respectively) (table 2 and fig 2).
During the first six postoperative months the risk of revision
for cemented implants was lower than that for each of the other
three types of fixation in all age groups studied (see
supplementary appendix 1 and fig 3).
Five year implant survival
The five year implant survival of uncemented total hip
replacements performed in 2006-11 was slightly inferior to
those performed in 1995-99 and in 2000-05. The five year
implant survival of cemented total hip replacements performed
in 2006-11was similar to those performed in 2000-05 and higher
than those performed in 1995-99 (see supplementary appendix
2).
Discussion
The survival of cemented implants for total hip replacement
was higher than that of uncemented implants in patients aged
65 years or older. The increased use of uncemented implants in
this age group is not supported by these data.
Strengths and limitations of this study
The major strength of our study is the unique collaboration of
four national registers to create a multinational database with a
high number of patients and a long follow-up time. Furthermore,
completeness and validity of data are high in the Nordic
countries. The main weakness of this study is that the minimal
dataset of the Nordic Arthroplasty Register Association includes
only basic information common to all national registers. Our
data do not include information on variables such as material
used for articulation, patient reported outcome measures,
patients’ state of health or comorbidity, activity levels, outcomes
on materials used, or surgical skills. The bearing surface might
be an important confounder when studying the association
between fixation type and risk of revision. Implant survival of
uncemented total hip replacement models with the highest
quality bearing surfaces may be noticeably higher than that of
the uncemented group as a whole. However, we believe that the
high number of implants in the current study makes the bias
from bearing surfaces tolerable. Furthermore, implant survival
may not be the only relevant outcome after total hip replacement.
It has been suggested that mortality is higher in the population
receiving cemented implants than in the population receiving
uncemented implants.14 However, mortality was not assessed
in the current study. In the future, analyses on mortality may
be performed based on information from theNordic Arthroplasty
Register Association database.
Comparison with other studies
Use of different implant fixation: time trend
The proportion of total hip replacements using uncemented
implants increased rapidly towards the end of the study period.
From 2006 to 2010 the proportion of uncemented implants has
also increased in several other countries with longer standing
register data, such as England and Wales, Australia, Canada,
and New Zealand.15 The proportion of uncemented total hip
replacements was 44% in England and Wales,8 14 64% in
Australia,9 47% in NewZealand24 in 2011, and 82% in Canada25
in 2010. The majority of total hip replacements in the United
States are performed with uncemented implants (86%).16
However, in New Zealand the proportion of total hip
replacements using uncemented implants fell for the first time
in years, from 52% in 2010 to 47% in 2011, with corresponding
increases in fully cemented and hybrid arthroplasties.24 Total
hip replacements using hybrid implants are more common in
England and Wales8 (18% in 2011), New Zealand24 (39% in
2011), and Australia9 (31% in 2011) than in Nordic countries.
The proportion of total hip replacements using hybrid implants
is decreasing in Nordic countries according to these data, but
not in Australia,9 England and Wales8 or New Zealand.24 The
proportion of total hip replacements using reverse hybrid
implants is increasing in the Nordic countries. In 2011 in
England and Wales, 15% of all total hip replacements using
hybrid or reverse hybrid implants were reverse hybrids.8
Implant survival
The risk of revision with cemented implants decreased during
the first six months after total hip replacement in all age groups
compared with all other fixation types, mainly as a result of a
few revision operations performed for periprosthetic fracture
or early aseptic loosening when using cemented implants.
Patients being considered for total hip arthroplasty should be
informed of an increased early risk of revision using fixation
methods other than cemented implants.
According to the current data the risk of revision from cemented
implants was decreased compared with all other fixation types
in patients aged 55 years or older. However, proportional hazard
assumption was not fulfilled in our Cox analyses for the whole
study period. The risk of revision from uncemented implants
was increased compared with that of cemented implants in the
oldest age groups in analysis of data from the National Joint
Registry of England and Wales (56% for 56-64 year old men,
54% for 56-64 year old women, 73% for men aged ≥65 years,
121% for women aged ≥65 years)8 and in Australia (40% for
both sexes aged ≥75 years).9 In Australia the overall risk of
revision from cemented implants was 48% higher than that of
uncemented implants in patients aged 55 to 64 years,9 which is
opposite to our findings. This difference may be caused by
different implant choices and bearing surfaces in Europe and
Australia. However, training and technical skills of orthopaedic
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surgeons may be as important to the survival of implants as the
choice of implant.26 Also, there may be geographical variation
in coping with the learning curve.
The overall risk of revision from hybrid implants was increased
48% compared with that of cemented implants in England and
Wales8 for men aged more than 65 years and 43% for similarly
aged women. In the age group 56 to 64 years the differences
between hybrid and cemented implants were not significant.8
In Australia the overall risk of revision from cemented implants
was increased 45% compared with that of hybrid implants in
the age groups 55 to 64 years and 29% in the age group 65 to
74 years.9 In the oldest age group the difference between hybrid
and cemented implants was not significant.9 The revision risk
of hybrid implants was increased compared with that of
cemented implants in all age groups in the current study. The
relatively poor survival of the hybrid implants in our study may
be related to choice of implant and type of polyethylene used
for articulation. In Australia and England, Exeter hybrids are
predominant and may skew the results towards better ones than
ours. Furthermore, longer follow-up in our study captures more
revisions related to wear and osteolysis and a higher proportion
of implants with poorly performing polyethylenes.27 The use of
reverse hybrid implants was suggested in the late 1990s as an
alternative to fully uncemented implants in younger patients
owing to the problem of wear of the conventional polyethylene
liners.4 Nowadays, reverse hybrid implants seem to be used
more as an alternative to fully cemented implants in more elderly
patients. The survival of reverse hybrid implants in our study
was inferior to that of the cemented implants in patients aged
65 years or older. This finding is in accordance with previous
data reporting an increased risk of early periprosthetic fractures28
and infections using reverse hybrid implants.29
The increasing move towards using uncemented implants in
Nordic countries has been certainly influenced by reports from
experts in single centres with good outcomes. However,
excellent implant survivorship has been reported for all kinds
of fixation techniques.30 31 In our opinion, intense marketing of
more expensive uncemented implants by industry has strongly
influenced the current trend. Willingness of orthopaedic
surgeons to adopt faster uncemented techniques with the ongoing
intense marketing has been high. The inferior five year survival
of uncemented implants for total hip replacements performed
during 2006-11 compared with those performed during 1995-99
or 2000-05 does not support continuing this trend.
Because proportional hazard assumption was not fulfilled in
our Cox analyses for the whole study period, we split the
follow-up in to one year intervals, except that the first year was
divided in to two periods. However, in a comparison of our data
with that of other registers we used risk ratios for the whole
interval from 1995 to 2011. We acknowledge that the use of
such risk estimates biases our results. However, proportional
hazard assumption may not have been fulfilled in analyses of
other national registers either. Owing to statistical issues
interpretation of comparisons based on data derived from diverse
national registers should be performed cautiously. Furthermore,
registers have different strategies for presenting data, which
may also be an obstacle to uniform interpretation of data on
revision risks.15 Hazard ratios and revision rate per 100
component years are both used.8-24 The use of component years
in reporting register results may be misleading since the type
and incidence of complications varies over time. For example,
during the first two postoperative years revisions due to
dislocations and infections will prevail, but with longer
follow-up there will be more revisions due to loosening. Also,
age groups may be defined differently among registers.15 A
worldwide database common to all national registers enabling
direct comparison of hip replacements would noticeably increase
the reliability of arthroplasty data.
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Tables
Table 1| Personal characteristics and data on fixation type for total hip replacements by age group. Values are numbers (percentages)
unless stated otherwise
Age groups (years)
AllCharacteristics ≥7565 to 7455 to 64
117 239 (33.7)139 937 (40.2)90 723 (26.1)347 899No of total hip replacements
39 119 (33.4)56 454 (40.3)41 469 (45.7)137 042 (39.4)Men
Diagnosis:
107 995 (92.1)128 562 (91.9)78 659 (86.7)315 216 (90.6)Primary osteoarthritis
3349 (2.9)2411 (1.7)2056 (2.3)7816 (2.3)Non-traumatic femoral head necrosis
2124 (1.8)3704 (2.6)2877 (3.2)8705 (2.5)Rheumatoid arthritis
1036 (0.9)2256 (1.6)4043 (4.5)7335 (2.1)Paediatric hip disease
2735 (2.3)3004 (2.1)3088 (3.4)8827 (2.5)Other
Fixation:
96 055 (81.9)96 346 (68.9)40 202 (44.3)232 603 (66.9)Cemented
9422 (8.0)26 940 (19.3)35 092 (38.7)71 454 (20.5)Uncemented
9013 (7.7)11 272 (8.1)7930 (8.7)28 215 (8.1)Hybrid
2749 (2.3)5379 (3.8)7499 (8.3)15 627 (4.5)Reverse hybrid
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Table 2| Unadjusted Kaplan-Meier survival data at 10 and 15 years for total hip replacements, by fixation type
15 year follow-up10 year follow-up
No of
revisions
No of total hip
replacements
Fixation type by age
group Survival (%) (95% CI)
No of patients at
riskSurvival (%) (95% CI)
No of patients at
risk
Cemented:
84.1 (83.4 to 84.8)288292.2 (91.8 to 92.5)13 626283240 20255-64
89.3 (88.9 to 89.7)538993.8 (93.6 to 94.0)29 031479996 34665-74
93.9 (93.5 to 94.3)183195.9 (95.8 to 96.1)17 570277596 055≥75
Uncemented:
82.8 (81.7 to 83.8)130891.8 (91.3 to 92.2)6102197735 09255-64
87.8 (86.4 to 89.0)45492.9 (92.3 to 93.4)2885116826 94065-74
—3093.0 (91.8 to 94.0)4583949422≥75
Hybrid:
80.7 (79.2 to 82.1)74190.0 (89.2 to 90.7)3685855793055-64
86.8 (85.6 to 87.9)54691.6 (90.9 to 92.2)373881011 27265-74
91.6 (89.8 to 93.1)10993.9 (93.1 to 94.5)13283709013≥75
Reverse hybrid:
—1992.4 (90.9 to 93.7)364243749955-64
—790.7 (87.3 to 93.2)119158537965-74
—393.2 (90.7 to 95.1)*401192749≥75
*Result is for 7.8 year survival (100 hips at risk at that time point).
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No of total hip
replacements





024 (12)0100 (49)9 (4)63 (31)8 (4)20440 20255-64
036 (6)4300 (51)20 (3)192 (33)34 (6)58696 34665-74
055 (7)4335 (45)28 (4)277 (37)46 (6)74596 055≥75
Uncemented:
373 (15)7137 (28)123 (25)85 (17)70 (14)49835 09255-64
250 (11)2130 (28)137 (29)81 (17)70 (15)47226 94065-74
020 (8)267 (28)73 (30)38 (16)43 (18)2439422≥75
Hybrid:
09 (10)247 (53)7 (8)17 (19)6 (7)88793055-64
09 (7)075 (57)6 (5)30 (23)12 (9)13211 27265-74
113 (11)061 (50)6 (5)30 (24)12 (10)1239013≥75
Reverse hybrid:
07 (11)014 (22)18 (28)15 (23)11 (17)65749955-64
020 (26)116 (21)14 (18)20 (26)6 (8)77537965-74
112 (14)115 (18)18 (21)29 (35)8 (10)842749≥75
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Figures
Fig 1 Yearly number of total hip replacements by fixation type in patients aged 55 years or older in Nordic Arthroplasty
Register Association database
Fig 2 Kaplan-Meier implant survival curves for total hip replacements by fixation type and age groups
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Fig 3 Hazard ratio for risk of revision of hybrid, reverse hybrid, and uncemented total hip replacements compared with
cemented fixation in patients by age group. Hazard ratios are presented in one year periods, except for the first year, which
has been divided into two periods. Hazard ratios are included for observations totaling at least 1000 at start of period
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